We believe that the intellectual property protection can be combined by this patent in Japan.

Home / neurosurgery / We believe that the intellectual property protection can be combined by this patent in Japan.

We believe that the intellectual property protection can be combined by this patent in Japan.

‘We believe that the intellectual property protection can be combined by this patent in Japan, with our American and European funds, established it of maximize the value of NB S101 in the major pharmaceutical markets around the world ‘said Philip J. President and Chief Executive Officer of Osteologix.

And Japan: Osteologix has now received patent protection for its new osteoporosis therapy in the three major pharmaceutical markets in the world.. Receives Positive Decision, a patent for Key Osteoporosis Drug Patent in Japan GrantOsteologix, announced that the Japanese Patent Office has a decision, a patent for Application Number 2006-504379 issued a decision: The / / bone conditions with water-soluble strontium salts . The claims include treatment of osteoporosis and related bone diseases with NB S101 , the Company’s lead osteoporosis drug candidate. The company expects that the patent will be granted by the end of 2009. The 20-year patent term expires in 2024.To Regional Cancer Program of Sudbury Regional Hospital in Sudbury, Ontario, is take over the first cancer plant at Canadian clinical to Clarity system in order to the impact of the lumpectomy hollow space movement adjust in their breast care. – ‘We hope radiotherapist to inspire the meeting to further examine the problem of thoracic movement of and detailed soft tissue cancer contoured in the planning as part of a conferences’ the overall theme the improve the Patient experiences,’said Tony Montefalco , founder and Chief Executive Officer of Resonant Medical. ‘as a Canadian, we are proud the dynamism and the recognition of the problem and how it affects patient treatment in Canadian radiotherapy community.

radiation. .. our Regional Cancer Program is enthusiastic innovative ultrasound innovative ultrasound technological to our patients, said Dr. Julie Bowen, Managers of Radiology Oncology at Sudbury Regional Hospital. tumors and organ movement of to soft tissues Crab is something previously adequately adequately in the Radiooncology joint. Now the Patients and physicians can be able itself know on out relieved that the radiation is just where it is required unnecessary while sparing healthy tissue radiation.